These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10849185)

  • 21. Extended interval aminoglycoside dosing: from concept to clinic.
    Maglio D; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2002 Apr; 19(4):341-8. PubMed ID: 11978505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily aminoglycosides: practical guidelines.
    Prins JM; Speelman P
    Neth J Med; 1998 Jan; 52(1):1-9. PubMed ID: 9573735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside dosing: one, two or three times a day?
    McLean AJ; Ioannides-Demos LL; Spicer WJ; Christophidis N
    Med J Aust; 1996 Jan; 164(1):39-42. PubMed ID: 8559095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?
    Zhanel GG; Ariano RE
    Ren Fail; 1992; 14(1):1-9. PubMed ID: 1561384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacodynamics of aminoglycosides.
    Lacy MK; Nicolau DP; Nightingale CH; Quintiliani R
    Clin Infect Dis; 1998 Jul; 27(1):23-7. PubMed ID: 9675444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides.
    Gilbert DN
    Clin Infect Dis; 1997 May; 24(5):816-9. PubMed ID: 9142774
    [No Abstract]   [Full Text] [Related]  

  • 28. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.
    Ali MZ; Goetz MB
    Clin Infect Dis; 1997 May; 24(5):796-809. PubMed ID: 9142772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single vs. multiple daily dosing of aminoglycosides.
    Cefalu CA
    Am Fam Physician; 1999 May; 59(9):2430, 2435. PubMed ID: 10323353
    [No Abstract]   [Full Text] [Related]  

  • 34. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dosing aminoglycosides once a day].
    Blaser J
    Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review.
    Hatala R; Dinh TT; Cook DJ
    Clin Infect Dis; 1997 May; 24(5):810-5. PubMed ID: 9142773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some international approaches to aminoglycoside monitoring in the extended dosing interval era.
    Morris RG; Sallustio BC; Vinks AA; LeGatt DF; Verjee ZH; El Desoky E
    Ther Drug Monit; 1999 Aug; 21(4):379-88. PubMed ID: 10442690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.